TY - JOUR
AU - 
AB - DRUG NEWS SEIZURE CONTROL HEART DISEASE Easy-to-use gel approved Aspirin saves lives after menopause for home use Aspirin reduces mortality risk in postmenopausal women with heart disease. In a A new rectal delivery system for large study, women taking 81 mg or 325 mg of aspirin a day had a 17% reduction in diazepam has been approved by all-cause mortality compared with women who didn’t take aspirin. the FDA. Called Diastat AcuDial Researchers analyzed data from almost 9,000 postmenopausal women with con- (Valeant Pharmaceuticals Interna- firmed cardiovascular disease enrolled in the Women’s Heart Initiative. Forty-six per- tional), it delivers rectal diazepam cent of the women took aspirin. The incidence of myocardial infarction (MI), stroke, and death from cardiovascular doses ranging from 5 to 20 mg and causes was down 15% in women who took 325 mg/day and 13% in those who can be used by a nonprofessional took 81 mg/day, compared with women who didn’t take aspirin. Although the caregiver for emergency seizure reductions in MI and stroke weren’t statistically significant, aspirin use was linked to treatment. It’s indicated for se- a 25% reduction in the cardiovascular mortality rate. The researchers found no dif- lected refractory patients with ferences 
TI - Diagnostic agent pulled from market
JF - Nursing2017
DA - 2006-02-01
UR - https://www.deepdyve.com/lp/wolters-kluwer-health/diagnostic-agent-pulled-from-market-1jQEOtQqOv
SP - 30
EP - 30
VL - 36
IS - 2
DP - DeepDyve
ER -